Detalhe da pesquisa
1.
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia
; 34(9): 2544, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665699
2.
LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia
; 33(6): 1501-1513, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607021
3.
Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death.
Oncotarget
; 7(18): 26120-36, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27027430
4.
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
J Exp Med
; 213(9): 1705-22, 2016 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27455953
5.
The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML.
Autophagy
; 11(7): 1114-29, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26029847
6.
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells.
Oncotarget
; 5(15): 6252-66, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25051369